Holiday pricing through Dec 25, 2026: 20% off single-grant packages, 25% off annual programs. See pricing

Serving clients in the US, UK and Australia+1 (844) 400-0525

US grant · JoAnn Martin Grantor

DoW Rare Cancers Resource and Community Development Award

See official listing Closes November 18, 2026

Official listing and how to apply

Source: Grants.gov · Last checked

Key facts

FunderJoAnn Martin Grantor
Part ofDepartment of Defense
Opportunity numberHT942526RCRPRCDA
Amount per awardSee official listing
Total funding available$5,600,000
OpensJune 17, 2026
ClosesNovember 18, 2026 (8 days left)
Who can applyOpen to anyone
Applicant types listedUnrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
State or areaNationwide
Cost sharing or matchNot required
StatusOpen
SourceGrants.gov
Last checkedNovember 10, 2026

About this grant

Summary from the official listing on Grants.gov:

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources and clinical or preclinical datasets that will advance the field of rare cancers research and ultimately improve outcomes for individuals with rare cancers. Research supporting this funding opportunity should fill one of the following major gaps:

  • Lack of research and clinical resources, including patient tissues, cell and tumor models.
  • Lack of communication and dissemination strategies within scientific and patient communities for sharing rare cancers research and clinical findings.
  • Lack of infrastructure for sharing data and other resources.
  • Lack of therapeutics and mechanistic research to inform treatment development.

Distinctive Features:

  • Documentation of plans for engagement and partnerships with Patient Advocates throughout the life cycle of the research study from development of the research question through execution of the study.
  • Community building and enhancement are key components.
  • A description of the dissemination and sustainability of the platform for scientific and/or clinical and patient community is required.
  • Preliminary data are not required but may be included to address feasibility.

Details are copied from the official source and can change. Check the official listing before you apply. Grant Writing Company is not affiliated with this funder.

Want an expert to write it with you?

Grant Writing Company researches funders, writes organization proposals to each funder's instructions, and checks the package before you submit. experience since 2006. Funders decide every award.

Book a free call See our services